Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup
BioNTech SE (NASDAQ:BNTX) has agreed to acquire InstaDeep Ltd, a technology company in the field of artificial intelligence (“AI”) and machine…
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients.
Israeli Study Shows Pfizer, Biontech Omicron COVID Booster Cuts Hospitalization in Over 65s
-Reuters
https://www.reuters.com/business/healthcare-pharmaceuticals/israeli-study-finds-omicron-covid-booster-cuts-hospitalization-65-2023-01-09/
Codexis Shares Up Following Reports China Is In Talks For Paxlovid Generic; Codexis In 2022 Announced Agreement With Pfizer To Supply Enzyme For The Manufacture Of Paxlovid
https://www.codexis.com/investors/news-events/press-releases/detail/330/codexis-announces-agreement-with-pfizer-to-supply
BioNTech Announces Strategic Partnership With U.K. Government To Provide Up To 10,000 Patients With Personalized mRNA Cancer Immunotherapies By 2030
Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech's footprint in the UK
BioNTech aims to design and roll out randomized
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
Valneva SE (NASDAQ:VALN) reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. The…